Disclose is the use of an effective amount of miR-1 and an inhibitor of miR-133 in the manufacture of a medicament for the treatment of a muscle injury in a subject, wherein said miR-1 and said inhibitor of miR-133 increase myocyte differentiation when administered in combination to a muscle injury site.